Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Clinical Remission by a Comprehensive Severe Asthma Management Strategy Guided by Airway Inflammometry and BioimagingSanti Nolasco, Melanie Kjarsgaard, Sylvia Lauks, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2017
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell ArteritisCarol A Langford, David Cuthbertson, Steven R Ytterberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2017
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu ArteritisCarol A Langford, David Cuthbertson, Steven R Ytterberg, et al.
Rheumatology (Oxford, England)|September 6, 2016
Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal studyMurray Baron, Janet Pope, David Robinson, et al.
Canadian Journal of Kidney Health and Disease|November 12, 2015
CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summaryLucy McGeoch, Marinka Twilt, Leilani Famorca, et al.
The Journal of Rheumatology|March 3, 2019
Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic VasculitisGunnar Tomasson, John T Farrar, David Cuthbertson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2011
IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitisJames M Kelley, Paul A Monach, Chuanyi Ji, et al.
The Journal of Rheumatology|November 3, 2015
CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated VasculitidesLucy McGeoch, Marinka Twilt, Leilani Famorca, et al.
Journal of Neurology|March 13, 2024
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational studyRuth Geraldes, Monica Santos, Cristina Ponte, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Pageof 8